Mice Model Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Mice Model Market size exceeded USD 9.5 billion in 2022 and will depict over 6% CAGR from 2023 to 2032, driven by rising demand for humanized mice models.
The genetic resemblance between mice and humans is positively influencing market growth and boosting the demand for mouse models in biomedical research. The positive inclination of researchers toward the study of human diseases using mouse models as humans share more than 95% of their protein-coding and over 28% of non-coding sequences with mice genome, is set to provide lucrative opportunities to the market.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Mice Model Market Size in 2022: | USD 9.5 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 - 2032 CAGR: | 6 |
| 2023 Value Projection: | USD 18 Billion |
| Historical Data for: | 2018 to 2022 |
| No of Pages: | 366 |
| Tables, Charts & Figures: | 773 |
| Segments Covered: | Mice, Technology, Application, Use, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls Challenges: |
|
Despite a positive outlook for the mice model market, ongoing developments of alternative methods for animal testing will negatively influence product adoption. Researchers are compelled to find strategies to save time and employ fewer animals in drug screening procedures since millions of experimental animals are utilized each year globally. Scientists have therefore devised other methods that would reduce the number of mice employed as research subjects. Nonetheless, promising developments in the field would aid in overcoming this issue.
In terms of mice, the inbred mice model market will reach over USD 4.5 billion by 2032. The growing adoption of inbred mice for studying the genetic bases of phenotypic variation and the rising use in cancer research for understanding the genetic basis of tumor development and cancer progression is bolstering segment development. For instance, inbred mice are commonly used to reproduce DIO models to reduce modeling time and attain stable metrics.
The mice model market revenue size from the CRISPR technology segment will reach more than USD 6 billion by the end of 2032. This is attributed to its cost-effectiveness, time efficiency, and convenience compared to traditional gene editing techniques such as transcription activators-like effective nucleases (TALENS). Moreover, growing awareness regarding the advantages of CRISPR technology is promoting product demand. A 2022 study highlighted that 54 of 85 isolates of enterococci species indicated a presence of CRISPR-Cas loci, accounting for more than 63% of total samples.
Regionally, North America accounted for over 80% of the mice model market revenue in 2022, attributed to the high prevalence of chronic diseases including diabetes and viral diseases. As per a recent report, by 2060, people under age 20 with type 2 diabetes would increase by approximately 675% in the U.S. Moreover, several research organizations in the region are also focusing on developing effective therapeutic drugs for the treatment of viral diseases, which is increasing the demand for mice models.
Some of the key players profiled in the mice model market report include
These firms engage in promising acquisitions and mergers to propel their market position.
Mice Model Industry News
Market Size, By Mice
Market Size, By Technology
Market Size, By Application
Market Size, By Use
Market Size, By End-use
The above information is provided for the following regions and countries:
The inbred segment is poised to reach over USD 4.5 million by 2032 as a result of the growing adoption of inbred mice for studying the genetic bases of phenotypic variation.
North America accounted for over 80% of the mice model market revenue in 2022, attributed to the high prevalence of chronic diseases including diabetes and viral diseases in the region.
CRISPR segment will register over USD 6 billion by 2032 owing to its cost-effectiveness, time efficiency, and convenience compared to traditional gene editing techniques.
Global market for mice model was valued at more than USD 9.5 billion in 2022 and will progress at over 6% CAGR between 2023 and 2032 propelled by rising demand for humanized mice models.
